M. Jiang

发表

Body mass index as a prognostic factor in patients with extranodal natural killer/T-cell lymphoma, nasal type

Na Li, Jie Liu, Yao-tiao Deng, 2016, Oncotarget.

Interleukin‐36α suppresses growth of non‐small cell lung cancer in vitro by reducing angiogenesis

M. Jiang, Haoyue Hu, X. Xiaoxiao, 2021, FEBS open bio.

Survey on breast cancer patients in China toward breast‐conserving surgery

X. Du, Li Zhang, M. Jiang, 2012, Psycho-oncology.

Low‐dose endostatin normalizes the structure and function of tumor vasculature and improves the delivery and anti‐tumor efficacy of cytotoxic drugs in a lung cancer xenograft murine model

Q. Peng, Na Lei, Helan Wang, 2012, Thoracic cancer.

Treatment of nasopharyngeal carcinoma with pulmonary tuberculosis and gout: A case report

Mei Li, M. Jiang, Dingyi Liu, 2014, Oncology letters.

Phase 2 trial of “Sandwich” L‐asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T‐cell lymphoma

Wenyan Zhang, Qun-pei Yang, Wei-ping Liu, 2012, Cancer.

PET/CT-based bone-marrow assessment shows potential in replacing routine bone-marrow biopsy in part of patients newly diagnosed with extranodal natural killer/T-cell lymphoma

Yiqin Wang, Jie Liu, R. Tian, 2019, Journal of Cancer Research and Clinical Oncology.

Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications

Xin-chuan Chen, M. Hou, D. Cao, 2011, Journal of experimental & clinical cancer research : CR.

Antiemetic activity of megestrol acetate in patients receiving chemotherapy

M. Qiu, F. Bi, J. Zang, 2011, Supportive Care in Cancer.

A 10-year survival update on early-stage extranodal natural killer/T-cell lymphoma with ‘sandwich’ therapy

Wenyan Zhang, Wei-ping Liu, Li Zhang, 2022, Acta oncologica.

Trial of LVDP regimen (l-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma

Y. Yang, M. Jiang, Yu Jiang, 2015, Medical Oncology.

Metastatic Pancreatic Cancer Response to Treatment with Cetuximab and Gemcitabine plus Capecitabine: A Case Report and Review of the Literature

Mei Li, M. Jiang, F. Luo, 2010, Tumori.

Clinical prognostic analysis of 116 patients with primary intestinal non-Hodgkin lymphoma

J. Zang, Xin-chuan Chen, D. Cao, 2012, Medical Oncology.

The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma

Na Li, M. Jiang, Wanchun Wu, 2022, Annals of Hematology.

Clinical characteristics of 45 patients with invasive pulmonary aspergillosis

Mei Li, M. Jiang, Yu Jiang, 2009, Cancer.

Prognostic Characteristics of Gastrointestinal Tract NK/T-Cell Lymphoma: An Analysis of 47 Patients in China

B. Zhang, Xin-chuan Chen, M. Jiang, 2013, Journal of clinical gastroenterology.

WFDC Protein: A Promising Diagnosis Biomarker of Ovarian Cancer

M. Jiang, Yajuan Zhu, Xiao-yan Wang, 2021, Journal of Cancer.

Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC)

M. Hou, D. Cao, Yu Yang, 2011, Medical oncology.

Unexpected Favorable Outcome to PD-1 Antibody Plus Lenvatinib in a Patient With Recurrent Intestinal Follicular Dendritic Cell Sarcoma: A Case Report and Literature Review

M. Jiang, Sha Zhao, Yanna Lei, 2021, Frontiers in Immunology.

Utilization of lung cancer cell lines for the study of lung cancer stem cells

Mei Li, M. Jiang, Yu-yi Wang, 2018, Oncology letters.

Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)

Z. Ge, Yuankai Shi, Liping Xie, 2021, Journal of Hematology & Oncology.

Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201)

Ligen Liu, Jun Zhu, Yu Hu, 2022, Frontiers in Oncology.

CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer

D. Cao, M. Jiang, Jiantao Wang, 2018, OncoTargets and therapy.

CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer

Feng Luo, D. Cao, M. Jiang, 2018, OncoTargets and therapy.

Antiangiogenic therapy using endostatin increases the number of ALDH+ lung cancer stem cells by generating intratumor hypoxia

F. Luo, Mei Li, M. Jiang, 2016, Scientific Reports.

Measurement of distress in Chinese inpatients with lymphoma

Yu‐quan Wei, Yisi Wang, M. Jiang, 2013, Psycho-oncology.

A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome

M. Hou, Yu Yang, Jiang Zhu, 2010, BMC Cancer.

Long-term follow-up of imatinib mesylate treatment for patients with recurrent gastrointestinal stromal tumor : liver metastases was not a predictor for poor outcome

M. Hou, Lin Zhou, Yu Yang, 2009 .

Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study

Hao Jiang, Jianxiang Wang, A. Sun, 2020, Clinical Cancer Research.

Primary Central Nervous System Burkitt Lymphoma With Non-Immunoglobulin Heavy Chain Translocation in Right Ventricle: Case Report

Y. Guan, Jiang Zhu, M. Jiang, 2011, Pediatric hematology and oncology.

How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome

Na Li, M. Jiang, L. Zou, 2021, Frontiers in Oncology.

Lymphoma-associated hemophagocytic syndrome: a retrospective study from a single center

Na Li, M. Jiang, Hui Zhou, 2022, Hematology.

Polarization of tumor‐associated macrophage is associated with tumor vascular normalization by endostatin

Q. Peng, Mei Li, S. Lei, 2013, Thoracic cancer.

Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells

F. Luo, D. Cao, Yan Li, 2016, Tumor Biology.

A phase II prospective study of the “Sandwich” protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma

R. Tian, Wenyan Zhang, Wei-ping Liu, 2017, OncoTarget.

Assessment of the prognostic capacity of pretreatment, interim, and post-therapy 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type

R. Tian, Xin Zhang, M. Jiang, 2015, Annals of Nuclear Medicine.

Intestinal epithelium-derived BATF3 promotes colitis-associated colon cancer through facilitating CXCL5-mediated neutrophils recruitment

H. Deng, Lin Cheng, J. Li, 2020, Mucosal Immunology.

Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications

Dan Cao, Yong-song Guan, Mei Hou, 2009, BMC Cancer.

Current Status of Out-of-Hospital Management of Cancer Patients and Awareness of Internet Medical Treatment: A Questionnaire Survey

Shuang Dai, M. Jiang, J. Miao, 2021, Frontiers in Public Health.

A pilot study of weekly docetaxel chemotherapy combined with regional hyperthermia for pretreated stage III non-small cell lung cancer

Yu Yang, Jiang Zhu, M. Jiang, 2008 .

Versican silencing improves the antitumor efficacy of endostatin by alleviating its induced inflammatory and immunosuppressive changes in the tumor microenvironment.

D. Cao, Yan Li, Mei Li, 2015, Oncology reports.

First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data.

Ying Cheng, F. Bi, X. Ren, 2019, Future oncology.

Hypoxia and TGF-β1 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumors

N. Zhang, Mei Li, M. Jiang, 2015, Cell & Bioscience.

Five‐year analysis from phase 2 trial of “sandwich” chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T‐cell lymphoma

Wenyan Zhang, Qun-pei Yang, Wei-ping Liu, 2015, Cancer medicine.

[Relationship between clinicopathologic characteristics and expression of VEGF-C and VEGF-D in esophageal squamous cancer].

M. Hou, D. Cao, Yu Yang, 2009, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

The Deauville 5-Point Scale Improves the Prognostic Value of Interim FDG PET/CT in Extranodal Natural Killer/T-Cell Lymphoma

R. Tian, M. Jiang, Chong Jiang, 2015, Clinical nuclear medicine.

A phase II study of penpulimab, an anti-PD-1 antibody, in patients with relapsed or refractoryclassic Hodgkin lymphoma (cHL).

Jun Zhu, Chuan Jin, Xiaoping Jin, 2021 .